Japanese Pharma Firm Joins Pfizer and Merck in Race to Develop COVID Pill Cure

Osaka-based Shionogi has joined Pfizer and Merck in a race to develop a daily pill that will neutralize COVID-19 in infected patients.

Barbie Latza Nadeau

Published Jul. 25 2021 11:00AM EDT 

Barbie Latza Nadeau

BLNadeau

Got a tip? Send it to The Daily Beast here.